Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.

Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores

Abstrato

Advancements in Chemotherapeutic Drug Delivery Carriers in Orthopedic Oncology

Sinus Berlin

Orthopedic oncology faces unique challenges in delivering chemotherapeutic drugs effectively while minimizing
systemic toxicity. Recent advancements in drug delivery systems have propelled the development of innovative carriers
designed to enhance targeted delivery to musculoskeletal tumors. This abstract provides a concise overview of these
advancements, focusing on key modalities such as nanoparticles, polymeric micelles, liposomes, hydrogels, and
magnetic drug delivery. These carriers offer the potential for precise and personalized treatment strategies, allowing
for increased drug bioavailability at the tumor site while minimizing adverse effects on healthy tissues. The abstract
underscores the transformative impact of these advancements on the future of orthopedic oncology, emphasizing the
potential for improved therapeutic outcomes and reduced treatment-related morbidity.